麻豆传媒

The Weston Family Foundation, through the Weston Brain Institute (the 鈥淚nstitute鈥�),听is committed to catalyzing and scaling science-based approaches to significantly improve the health and well-being of Canadians.
听
They are pleased to announce the launch of the flagship Rapid Response program, designed to spark the development of novel therapeutics and tools for neurodegenerative diseases of aging (NDAs). 听

Eligible projects should meet the following criteria:

• Be translational research that can accelerate therapeutic or tool development for NDAs, as defined by the Institute.
  • Therapeutics should address unmet needs in the prevention, treatment and/or symptomatic management of NDAs.
  • Tools should address challenges in translational research to accelerate the development and/or clinical implementation of therapeutics for NDAs (e.g., biomarkers, drug delivery systems).
• Have preliminary data to support the hypothesis and feasibility of the project.

Funding per project: Up to $300,000 over 18-24 months.

Important dates:

• Program information session:听 February 11, 2025 (register ).
• Letter of Intent deadline: March 18, 2025 ()听
• Award announcement: November 2025

For more information about this program, including details on project and applicant eligibility, Institute definitions, program review criteria and expected project outcomes, please to access the RFA, the Program Details document and the Letter of Intent template.

Unless otherwise specified, the standard ORS internal deadline is 10 business days ahead of the funder deadline. Researchers are encouraged to check with their faculty regarding their incremental internal deadline.听

罢丑别鈥�grants facilitator鈥痜or your faculty or this opportunity can be found on the staff contact page. For additional resources,鈥�鈥痆login required] on听 internal deadlines and submission processes.听